WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

WHO today accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms. The Solidarity Trial was established by WHO to find an https://cfi.co/c-19-press/2020/07/who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19/ https://cfi.co/c-19-press/2020/07/who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19/